Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.thromres.2020.10.001 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum "rivaroxaban
4
"rivaroxaban apixaban
4
apixaban fragile
4
fragile patients
4
patients acute
4
acute venous
4
venous thromboembolism"
4
thromboembolism" [thromb
4
[thromb res
4
res 193
4
Similar Publications
Corrigendum to "Evaluation of rivaroxaban amorphous solid dispersions physical stability via molecular mobility studies and molecular simulations" [European Journal of Pharmaceutical Sciences 157 (2021) 105642].
Eur J Pharm Sci
January 2025
Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece. Electronic address:
Corrigendum: Evaluation of herb-drug interaction between Danshen and rivaroxaban in rat and human liver microsomes.
Front Pharmacol
October 2022
Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China.
[This corrects the article DOI: 10.3389/fphar.2022.
View Article and Find Full Text PDFCorrigendum to "Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism" [Thromb. Res. 193 (2020) 160-165].
Thromb Res
December 2021
Department of Medicine, Universidad Autónoma de Barcelona, Spain; Department of Internal Medicine, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!